IS6085A - Lyfjablanda með kítósan óligómerum - Google Patents

Lyfjablanda með kítósan óligómerum

Info

Publication number
IS6085A
IS6085A IS6085A IS6085A IS6085A IS 6085 A IS6085 A IS 6085A IS 6085 A IS6085 A IS 6085A IS 6085 A IS6085 A IS 6085A IS 6085 A IS6085 A IS 6085A
Authority
IS
Iceland
Prior art keywords
oligomers
treatment
medication
compositions
chitosan oligomers
Prior art date
Application number
IS6085A
Other languages
English (en)
Icelandic (is)
Inventor
M. Einarsson Jon
Gíslason Johannes
Peter Martin
Original Assignee
Genis Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genis Ehf. filed Critical Genis Ehf.
Priority to IS6085A priority Critical patent/IS6085A/is
Priority to PCT/IS2002/000016 priority patent/WO2003026677A1/en
Priority to AT02777769T priority patent/ATE359797T1/de
Priority to EP02777769A priority patent/EP1435976B1/en
Priority to SI200230558T priority patent/SI1435976T1/sl
Priority to US10/490,637 priority patent/US7985741B2/en
Priority to DE60219653T priority patent/DE60219653T2/de
Priority to ES02777769T priority patent/ES2284935T3/es
Priority to JP2003530312A priority patent/JP4613008B2/ja
Priority to KR10-2004-7004323A priority patent/KR20040062548A/ko
Priority to PT02777769T priority patent/PT1435976E/pt
Priority to DK02777769T priority patent/DK1435976T3/da
Priority to CA2507926A priority patent/CA2507926C/en
Publication of IS6085A publication Critical patent/IS6085A/is
Priority to IS7193A priority patent/IS2783B/is
Priority to US13/164,397 priority patent/US8415326B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS6085A 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum IS6085A (is)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
ES02777769T ES2284935T3 (es) 2001-09-26 2002-09-26 Composicion farmaceutica que comprende quitooligomeros.
JP2003530312A JP4613008B2 (ja) 2001-09-26 2002-09-26 キト−オリゴマーを含む医薬組成物
EP02777769A EP1435976B1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
SI200230558T SI1435976T1 (sl) 2001-09-26 2002-09-26 Farmacevtski sestavek, ki obsega hito-oligomere
US10/490,637 US7985741B2 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
DE60219653T DE60219653T2 (de) 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito-oligomeren
PCT/IS2002/000016 WO2003026677A1 (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
AT02777769T ATE359797T1 (de) 2001-09-26 2002-09-26 Pharmazeutische zusammensetzung mit chito- oligomeren
KR10-2004-7004323A KR20040062548A (ko) 2001-09-26 2002-09-26 키토-올리고머를 함유하는 약학 조성물
PT02777769T PT1435976E (pt) 2001-09-26 2002-09-26 Composição farmacêutica incluindo quito-oligómeros
DK02777769T DK1435976T3 (da) 2001-09-26 2002-09-26 Farmaceutisk sammensætning indeholdende chito-oligomerer
CA2507926A CA2507926C (en) 2001-09-26 2002-09-26 Pharmaceutical composition comprising chito-oligomers
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður
US13/164,397 US8415326B2 (en) 2001-09-26 2011-06-20 Pharmaceutical composition comprising chito-oligomers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum

Publications (1)

Publication Number Publication Date
IS6085A true IS6085A (is) 2003-03-27

Family

ID=36700489

Family Applications (2)

Application Number Title Priority Date Filing Date
IS6085A IS6085A (is) 2001-09-26 2001-09-26 Lyfjablanda með kítósan óligómerum
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7193A IS2783B (is) 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður

Country Status (13)

Country Link
US (2) US7985741B2 (cg-RX-API-DMAC7.html)
EP (1) EP1435976B1 (cg-RX-API-DMAC7.html)
JP (1) JP4613008B2 (cg-RX-API-DMAC7.html)
KR (1) KR20040062548A (cg-RX-API-DMAC7.html)
AT (1) ATE359797T1 (cg-RX-API-DMAC7.html)
CA (1) CA2507926C (cg-RX-API-DMAC7.html)
DE (1) DE60219653T2 (cg-RX-API-DMAC7.html)
DK (1) DK1435976T3 (cg-RX-API-DMAC7.html)
ES (1) ES2284935T3 (cg-RX-API-DMAC7.html)
IS (2) IS6085A (cg-RX-API-DMAC7.html)
PT (1) PT1435976E (cg-RX-API-DMAC7.html)
SI (1) SI1435976T1 (cg-RX-API-DMAC7.html)
WO (1) WO2003026677A1 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2507870A1 (en) * 2001-12-13 2003-07-03 Ism Biopolymer Inc. Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
CA2540586A1 (en) * 2003-10-01 2005-04-21 Optimer Pharmaceuticals, Inc. Treatment of a condition in a mammal with administration of aminosugar and uses thereof
JP2007525486A (ja) * 2003-11-24 2007-09-06 オプティマー・ファーマスーティカルズ・インコーポレイテッド 化合物の投与による哺乳動物の症状の処置及び化合物の使用方法
WO2005112948A1 (ja) * 2004-05-21 2005-12-01 Tottori University 創傷の治療又は処置のための薬剤
BRPI0612034A2 (pt) * 2005-06-14 2012-08-28 Genis Ehf método para recuperar polìmero de quitina parcialmente desacetilado totalmente solúvel e elevadamente puro, composição de polìmero de quitina parcialmente desacetilado, e, composição farmacêutica
US7485718B2 (en) 2005-06-16 2009-02-03 E. I. Du Pont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
WO2007001283A2 (en) * 2005-06-16 2007-01-04 E.I. Dupont De Nemours And Company Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) * 2006-06-22 2008-05-22 부경대학교 산학협력단 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
CA2731201C (en) * 2008-07-18 2018-10-16 Genis Ehf. Composition for treating autoimmune disorders
KR20100060634A (ko) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) * 2009-07-28 2017-04-26 (주)아모레퍼시픽 키토올리고당을 함유하는 피로회복용 조성물
WO2012167226A2 (en) 2011-06-03 2012-12-06 Maguire Abbey, Llc Method, composition, and articles for improving joint lubrication
NZ737873A (en) 2011-09-08 2019-05-31 Novozymes Bioag As Seed treatment methods and compositions
CN104093680B (zh) 2011-09-14 2016-08-24 诺维信生物农业公司 组合使用脂壳寡糖和/或壳寡糖与解磷微生物促植物生长
WO2013044208A2 (en) 2011-09-23 2013-03-28 Novozymes Biologicals Holdings A/S Chitooligosaccharides and methods for use in enhancing plant growth
CA2849901A1 (en) * 2011-09-23 2013-03-28 Novozymes Bioag A/S Chitooligosaccharides and methods for use in enhancing corn growth
CN104470550A (zh) 2012-04-23 2015-03-25 杰尼斯公共有限公司 作为骨移植替代物的含有部分脱乙酰壳多糖的自硬化生物活性接合剂组合物
JP6285497B2 (ja) * 2016-06-07 2018-02-28 株式会社エバーライフ 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko) 2016-07-14 2016-11-08 김기혁 공정가스 반응물의 콜드트랩 장치
WO2023205718A2 (en) * 2022-04-21 2023-10-26 Hassan Ameer E Methods of treating inflammation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919122B2 (ja) * 1976-10-12 1984-05-02 味の素株式会社 水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja) * 1986-12-19 1996-08-21 ライオン株式会社 骨疾患治療剤
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
US6117851A (en) * 1996-12-13 2000-09-12 Lescarden Inc. Treatment of osteoarthritis by administering poly-N-acetyl-D-glucosamine
JP3062592B2 (ja) * 1997-05-30 2000-07-10 農林水産省食品総合研究所長 ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en) * 2000-02-22 2001-08-29 Food Industry Research and Development Institute Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en) * 2000-03-15 2009-06-09 Cargill, Incorporated Chitosan and method of preparing chitosan
US20020119949A1 (en) 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
BRPI0612034A2 (pt) * 2005-06-14 2012-08-28 Genis Ehf método para recuperar polìmero de quitina parcialmente desacetilado totalmente solúvel e elevadamente puro, composição de polìmero de quitina parcialmente desacetilado, e, composição farmacêutica

Also Published As

Publication number Publication date
US8415326B2 (en) 2013-04-09
IS2783B (is) 2012-05-15
US20050004073A1 (en) 2005-01-06
US20110257381A1 (en) 2011-10-20
KR20040062548A (ko) 2004-07-07
IS7193A (is) 2004-03-22
ATE359797T1 (de) 2007-05-15
CA2507926A1 (en) 2003-04-03
ES2284935T3 (es) 2007-11-16
EP1435976B1 (en) 2007-04-18
CA2507926C (en) 2011-12-20
PT1435976E (pt) 2007-06-28
JP2005507891A (ja) 2005-03-24
DK1435976T3 (da) 2007-08-27
JP4613008B2 (ja) 2011-01-12
SI1435976T1 (sl) 2007-08-31
DE60219653D1 (de) 2007-05-31
DE60219653T2 (de) 2008-01-03
WO2003026677A1 (en) 2003-04-03
EP1435976A1 (en) 2004-07-14
US7985741B2 (en) 2011-07-26

Similar Documents

Publication Publication Date Title
IS6085A (is) Lyfjablanda með kítósan óligómerum
EP2085780A3 (en) Methods and products related to low molecular weight heparin
EA202193053A1 (ru) Хитозан и его применения
AU2003901834A0 (en) Cross-linked polysaccharide compositions
ATE479453T1 (de) Polymermischungen von anionischen und kationischen polysacchariden und verwendung davon
BR0007985A (pt) Processo para a preparação de derivados multiplamente reticulados do ácido hialurÈnico (ha), ha multiplamente reticulado, ha reticulado em um ou mais polìmeros diferentes de ha, ha reticulado em um segundo polìmero, produto, e, uso de um derivado de ha multiplamente reticulado
EP0625507A3 (en) Urea derivatives and their use as acat inhibitors
MX375577B (es) Composiciones de derivados de quitina parcialmente desacetilados.
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
BR9913658A (pt) Frações de inulina, processo para a sua preparação e produtos alimentìcios contendo as ditas frações de inulina
JP2005507891A5 (cg-RX-API-DMAC7.html)
ATE441333T1 (de) Zusammensetzung enthaltend oligosaccharide als lísliche ballaststoffe zur verwendung gegen muskelschwund
ES2161615A1 (es) Composiciones de heparinas de muy bajo peso molecular.
SV2003001201A (es) Preparados de chitosan
DK0960132T3 (da) Polysaccharid, mikroorganisme og fremgangsmåde til fremstilling deraf, præparat med indhold deraf samt anvendelse
IS6914A (is) 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
DE60039201D1 (de) Herstellung von Chitin und Chitosan
TW200510012A (en) Aqua gel comprising temperature effect
DK1366082T3 (da) Höjsulfaterede derivater af K5-polysaccharid og deres fremstilling
ATE328603T1 (de) Modulatoren von polysacchariden und deren verwendungen
BR9609416A (pt) Agentes antivìrus.
ATE486607T1 (de) Viskosupplementation mit algen-polysacchariden bei der behandlung von arthritis
EP2301554A8 (en) Composition for the treatment of osteoarthritis
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
BR0313613A (pt) Variantes do principal alérgeno phl p 1 de capim-timóteo